What is Tpoxx? The Monkeypox Treatment Drug That’s Hard to Get
Doctors who want to prescribe tecovirimat, or Tpoxx, must navigate a gantlet of bureaucratic hurdles that experts say could be quickly lifted.
Doctors who want to prescribe tecovirimat, or Tpoxx, must navigate a gantlet of bureaucratic hurdles that experts say could be quickly lifted.
Doctors who want to prescribe tecovirimat, or Tpoxx, must navigate a gantlet of bureaucratic hurdles that experts say could be quickly lifted.
The deal would end thousands of lawsuits against one of the largest producers of opioid painkillers during the height of the opioid epidemic.
The deal would end thousands of lawsuits against one of the largest producers of opioid painkillers during the height of the opioid epidemic.
The deal would end thousands of lawsuits against one of the largest producers of opioid painkillers during the height of the opioid epidemic.
Demand for medication abortion is surging, setting the stage for new legal battles.
The drug, crenezumab, failed to prevent early symptoms or slow cognitive decline, the latest setback in the long quest to find effective therapies for the […]
The drug, crenezumab, failed to prevent early symptoms or slow cognitive decline, the latest setback in the long quest to find effective therapies for the […]
The drug, crenezumab, failed to prevent early symptoms or slow cognitive decline, the latest setback in the long quest to find effective therapies for the […]
El medicamento, de Eli Lilly, ya se emplea para la artritis reumatoide y, en muchos pacientes, restablece el crecimiento del cabello. Pronto podría haber otros […]
El medicamento, de Eli Lilly, ya se emplea para la artritis reumatoide y, en muchos pacientes, restablece el crecimiento del cabello. Pronto podría haber otros […]
The F.D.A. is also reviewing the treatment, Albrioza, but the agency’s scientists have raised questions about its effectiveness.
The drug, made by Eli Lilly, is already used for rheumatoid arthritis, and could be followed by two more drugs from other companies.
The drug, made by Eli Lilly, is already used for rheumatoid arthritis, and could be followed by two more drugs from other companies.
The F.D.A. is also reviewing the treatment, Albrioza, but the agency’s scientists have raised questions about its effectiveness.
A new clinical trial is the largest to date testing the antiparasitic drug on people with Covid.
As the number of cases outside Africa approaches 800, governments are scrambling for a limited pool of vaccines and treatments with unclear effectiveness.
MDMA-assisted treatment for post-traumatic stress disorder “represents real hope for long-term healing,” health experts say.
The soaring drug fatalities in the U.S. are being fueled partly by fentanyl-tainted pills bought by teenagers and young adults on Snapchat, Instagram, TikTok and […]
A clinical trial will be needed to verify the research, which offered a warning about taking steroids or nonprescription drugs to soothe aches that many […]
Antibody levels rose in the children who received it, suggesting the vaccine protects against infection. But the data were gathered before the arrival of Omicron.
Antibody levels rose in the children who received it, suggesting the vaccine protects against infection. But the data were gathered before the arrival of Omicron.
Antibody levels rose in the children who received it, suggesting the vaccine protects against infection. But the data were gathered before the arrival of Omicron.
A clinical trial will be needed to verify the research, which offered a warning about taking steroids or nonprescription drugs for weeks on end.
A clinical trial will be needed to verify the research, which offered a warning about taking steroids or nonprescription drugs for weeks on end.
El panorama de la atención a la salud mental de los adolescentes en EE. UU. es cada vez más similar al consultorio de esta doctora […]
El panorama de la atención a la salud mental de los adolescentes en EE. UU. es cada vez más similar al consultorio de esta doctora […]
El panorama de la atención a la salud mental de los adolescentes en EE. UU. es cada vez más similar al consultorio de esta doctora […]
El panorama de la atención a la salud mental de los adolescentes en EE. UU. es cada vez más cada similar al consultorio de esta […]
Around the country, the setting for adolescent mental health care looks ever more like this doctor’s office in Kentucky, the next patient arriving every 15 […]
Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.
A late-stage trial was halted after strong early results, according to the company, but outside scientists have not yet seen the data.
The Alzheimer’s Association has pushed relentlessly to get broad access to Aduhelm, despite safety risks and uncertain evidence that it helps patients.
With a 6-4 vote, the group of independent advisers to the agency narrowly concluded that results from another clinical trial are needed to assess whether […]
“At some point it will become a waste of resources to continue studying an unpromising approach,” one expert said.
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
It’s not clear whether three doses of the Pfizer-BioNTech vaccine will adequately protect young children. But the F.D.A. may authorize the first two doses anyway.
No está claro si tres dosis de la vacuna Pfizer-BioNTech protegerán adecuadamente a los niños. Pero es posible que la FDA autorice las primeras dos […]
No está claro si tres dosis de la vacuna Pfizer-BioNTech protegerán adecuadamente a los niños. Pero es posible que la FDA autorice las primeras dos […]
The agency threw out previous recommended limits on doses but encouraged “nonopioid therapies” wherever possible.
It’s not clear whether three doses of the Pfizer-BioNTech vaccine will adequately protect young children. But the F.D.A. may authorize the first two doses anyway.
Medicare officials are trying to determine whether to cover Aduhelm, which the F.D.A. approved despite unclear evidence that it helps patients.
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.
A group of Alzheimer’s experts and health advocates called on the F.D.A. to withdraw its approval of the drug, the latest of several setbacks for […]
A group of Alzheimer’s experts and health advocates called on the F.D.A. to withdraw its approval of the drug, the latest of several setbacks for […]
A group of Alzheimer’s experts and health advocates called on the F.D.A. to withdraw its approval of the drug, the latest of several setbacks for […]
A group of Alzheimer’s experts and health advocates called on the F.D.A. to withdraw its approval of the drug, the latest of several setbacks for […]
The treatment, called Paxlovid, is likely to work against Omicron and could be available in the United States before the end of the year.
The treatment, called Paxlovid, is likely to work against Omicron and could be available in the United States before the end of the year.
The treatment, called Paxlovid, is likely to work against Omicron and could be available in the United States before the end of the year.
The treatment, called Paxlovid, is likely to work against Omicron and could be available in the United States before the end of the year.
Some laboratory studies suggest that molnupiravir can insert errors in DNA, which could in theory harm a developing fetus, sperm cells or children.
Some laboratory studies suggest that molnupiravir can insert errors in DNA, which could in theory harm a developing fetus, sperm cells or children.
Some laboratory studies suggest that molnupiravir can insert errors in DNA, which could in theory harm a developing fetus, sperm cells or children.
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Merck and Pfizer will soon debut prescription pills to treat Covid-19. And more drugs are on the way.
Merck and Pfizer will soon debut prescription pills to treat Covid-19. And more drugs are on the way.
Merck and Pfizer will soon debut prescription pills to treat Covid-19. And more drugs are on the way.
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen […]
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen […]
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen […]
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen […]
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
Una “mezcla tipo Frankenstein” de mutaciones suscita preocupación, pero la variante puede seguir siendo vulnerable a las vacunas actuales. Si no es así, serán necesarias […]
Una “mezcla tipo Frankenstein” de mutaciones suscita preocupación, pero la variante puede seguir siendo vulnerable a las vacunas actuales. Si no es así, serán necesarias […]
Una “mezcla tipo Frankenstein” de mutaciones suscita preocupación, pero la variante puede seguir siendo vulnerable a las vacunas actuales. Si no es así, serán necesarias […]
Una “mezcla tipo Frankenstein” de mutaciones suscita preocupación, pero la variante puede seguir siendo vulnerable a las vacunas actuales. Si no es así, serán necesarias […]
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many […]
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many […]
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many […]
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many […]
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many […]
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many […]
In one of the first cases to be brought against drug manufacturers over the crisis, a judge ruled that there was “simply no evidence” the […]
In one of the first cases to be brought against drug manufacturers over the crisis, a judge ruled that there was “simply no evidence” the […]
In one of the first cases to be brought against drug manufacturers over the crisis, a judge ruled that there was “simply no evidence” the […]
In one of the first cases to be brought against drug manufacturers over the crisis, a judge ruled that there was “simply no evidence” the […]
Most Medicare beneficiaries don’t compare plans during open enrollment season, and may be paying more, or accepting more restrictions, than they should.
Most Medicare beneficiaries don’t compare plans during open enrollment season, and may be paying more, or accepting more restrictions, than they should.
The poll also found that many of the unvaccinated believe that a push for booster shots shows that the inoculations are not working.
The pandemic has exposed flaws in services for people who can’t easily access a drive-through window for Covid shots or testing or can’t read prescription […]
The pandemic has exposed flaws in services for people who can’t easily access a drive-through window for Covid shots or testing or can’t read prescription […]
The pandemic has exposed flaws in services for people who can’t easily access a drive-through window for Covid shots or testing or can’t read prescription […]
The pandemic has exposed flaws in services for people who can’t easily access a drive-through window for Covid shots or testing or can’t read prescription […]
Too often, seniors who use opioids become targets for exploitation and abuse.
Too often, seniors who use opioids become targets for exploitation and abuse.
Too often, seniors who use opioids become targets for exploitation and abuse.
Too often, seniors who use opioids become targets for exploitation and abuse.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Too often, seniors who use opioids become targets for exploitation and abuse.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Prescriptions for ivermectin have jumped to more than 88,000 per week, some pharmacists are reporting shortages and people are overdosing on forms of the drug […]
Researchers ended a large trial in South Africa after finding that an experimental vaccine offered little protection.
The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” committee leaders said in a letter.
The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” committee leaders said in a letter.
The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” committee leaders said in a letter.
Researchers ended a large trial in South Africa after finding that an experimental vaccine offered little protection.
Prescriptions for ivermectin have jumped to more than 88,000 per week, some pharmacists are reporting shortages and people are overdosing on forms of the drug […]
Prescriptions for ivermectin have jumped to more than 88,000 per week, some pharmacists are reporting shortages and people are overdosing on forms of the drug […]
In a rare courtroom appearance, the former Purdue Pharma president and board member was evasive and defiant.
In a rare courtroom appearance, the former Purdue Pharma president and board member was evasive and defiant.
If approved by a judge next month, the plan would resolve thousands of lawsuits and set in motion the release of $4.5 billion to help […]
If approved by a judge next month, the plan would resolve thousands of lawsuits and set in motion the release of $4.5 billion to help […]
Muchos de los que recibieron la vacuna pueden necesitar refuerzos, dijeron los autores. Pero las autoridades sanitarias federales no recomiendan segundas dosis.
Muchos de los que recibieron la vacuna pueden necesitar refuerzos, dijeron los autores. Pero las autoridades sanitarias federales no recomiendan segundas dosis.
Many who received the shot may need to consider boosters, the authors said. But federal health officials do not recommend second doses.
The agreement would end thousands of lawsuits against the three largest distributors and Johnson & Johnson and require them to pay billions for addiction treatment […]
Many who received the shot may need to consider boosters, the authors said. But federal health officials do not recommend second doses.
Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.
The agreement would end thousands of lawsuits against the three largest distributors and Johnson & Johnson and require them to pay billions for addiction treatment […]
Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.
The major medical center’s rejection of the new Alzheimer’s drug is one of the starkest signs of concern over its effectiveness.
Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it.
Scientists were critical of the announcement, pointing to evidence that the current two-dose regimen is powerfully effective against the coronavirus.
Scientists were critical of the announcement, pointing to evidence that the current two-dose regimen is powerfully effective against the coronavirus.
The approval of Aduhelm to treat Alzheimer’s disease has raised hope among older adults, but many doctors wonder if it is warranted.
The approval of Aduhelm to treat Alzheimer’s disease has raised hope among older adults, but many doctors wonder if it is warranted.
France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like […]
France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like […]
A new workshop explores the right of Indigenous people to govern the collection, ownership and use of their biological and cultural data.
A new workshop explores the right of Indigenous people to govern the collection, ownership and use of their biological and cultural data.
Even those who supported the F.D.A.’s approval of the controversial new drug said authorizing it for anyone with Alzheimer’s disease was much too broad.
A new workshop explores the right of Indigenous people to govern the collection, ownership and use of their biological and cultural data.
The experimental treatment relies on radioactive molecules that seek out tumor cells, a strategy that may be useful against other cancers.
The experimental treatment relies on radioactive molecules that seek out tumor cells, a strategy that may be useful against other cancers.
The experimental treatment relies on radioactive molecules that seek out tumor cells, a strategy that may be useful against other cancers.
The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients.
The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients.
Even with U.N.’s previous goals unmet, delegates tried to water down provisions regarding protections for vulnerable populations and patents for essential drugs.
Even with U.N.’s previous goals unmet, delegates tried to water down provisions regarding protections for vulnerable populations and patents for essential drugs.
Older adults often take more medications than they need, or than is safe. Increasingly, geriatric experts and their patients are exploring the benefits of “deprescribing.”
Older adults often take more medications than they need, or than is safe. Increasingly, geriatric experts and their patients are exploring the benefits of “deprescribing.”
If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say […]
If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say […]
If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say […]
Regulators allowed a new antifungal treatment, but critics say it is unneeded and costs too much.
Regulators allowed a new antifungal treatment, but critics say it is unneeded and costs too much.
Regulators OK’d a new antifungal treatment, but critics say it is unneeded and costs too much.
Regulators OK’d a new antifungal treatment, but critics say it is unneeded and costs too much.
The shots may allow millions of youngsters to get back to school, camps, sleepovers and hangouts with friends.
The shots may allow millions of youngsters to get back to school, camps, sleepovers and hangouts with friends.
The shots may allow millions of youngsters to get back to school, camps, sleepovers and hangouts with friends.
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
The agency said it would stop enforcing a rule requiring women to get the first of two pills in person at a medical clinic or […]
The agency said it would stop enforcing a rule requiring women to get the first of two pills in person at a medical clinic or […]
The agency said it would stop enforcing a rule requiring women to get the first of two pills in person at a medical clinic or […]
Una nueva formulación que está entrando en ensayos clínicos en Brasil, México, Tailandia y Vietnam podría cambiar la forma en que el mundo combate la […]
Una nueva formulación que está entrando en ensayos clínicos en Brasil, México, Tailandia y Vietnam podría cambiar la forma en que el mundo combate la […]
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
Many scientists are expecting another rise in infections. But this time the surge will be blunted by vaccines and, hopefully, widespread caution. By summer, Americans […]
After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.
After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.
After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.
After ending its own Covid-19 vaccine trials, the company said that it was actively discussing with governments how to help its competitors make their shots.
After ending its own Covid-19 vaccine trials, the company said that it is actively discussing with governments how to help its competitors make their shots.
After ending its own Covid-19 vaccine trials, the company said that it is actively discussing with governments how to help its competitors make their shots.
Scientists are exploring the physics of viruses, to understand how these pathogens assemble themselves — and might be rent apart.
Scientists are exploring the physics of viruses, to understand how these pathogens assemble themselves — and might be rent apart.
Scientists are exploring the physics of viruses, to understand how these pathogens assemble themselves — and might be rent apart.
Scientists are exploring the physics of viruses, to understand how these pathogens assemble themselves — and might be rent apart.
A combination of two injectable drugs will provide an alternative to daily pills for people with H.I.V.
A combination of two injectable drugs will provide an alternative to daily pills for people with H.I.V.
A combination of two injectable drugs will provide an alternative to daily pills for people with H.I.V.
A combination of two injectable drugs will provide an alternative to daily pills for people with H.I.V.
A combination of two injectable drugs will provide an alternative to daily pills for people with H.I.V.
A combination of two injectable drugs will provide an alternative to daily pills for people with H.I.V.
Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That’s not wise, health experts say.
Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That’s not wise, health experts say.
Distributing supplies is a daunting logistical challenge, involving sophisticated tracking equipment, military contingencies and tight security.
Un panel asesor de los CDC decidirá sus recomendaciones el martes por la tarde. Esto es lo que esperamos, junto con las respuestas a otras […]
A C.D.C. advisory panel will decide on its recommendations on Tuesday afternoon. Here’s what we expect, along with answers to other questions about the new […]
Researchers at DeepMind say they have solved “the protein folding problem,” a task that has bedeviled scientists for more than 50 years.
A large team of regulators at the agency will take about three weeks to review an application spanning thousands of pages.
Copyright © 2024 | WordPress Theme by MH Themes